Investigation of new ferrocenyl-artesunate derivatives as antiparasitics.
Autor: | Munnik BL; Department of Chemistry and Polymer Science, Stellenbosch University, Stellenbosch, Western Cape, South Africa. pchellan@sun.ac.za., Kaschula CH; Department of Chemistry and Polymer Science, Stellenbosch University, Stellenbosch, Western Cape, South Africa. pchellan@sun.ac.za., Harding CR; Wellcome Centre for Integrative Parasitology, Institute of Infection, Immunity and inflammation, University of Glasgow, UK., Chellan P; Department of Chemistry and Polymer Science, Stellenbosch University, Stellenbosch, Western Cape, South Africa. pchellan@sun.ac.za. |
---|---|
Jazyk: | angličtina |
Zdroj: | Dalton transactions (Cambridge, England : 2003) [Dalton Trans] 2023 Nov 07; Vol. 52 (43), pp. 15786-15797. Date of Electronic Publication: 2023 Nov 07. |
DOI: | 10.1039/d3dt02254d |
Abstrakt: | Artesunate (Ars) is a semisynthetic antimalarial drug and is a part of the artemisinin-based combination therapy arsenal employed for malaria treatment. The drug functions mainly by activation of its endoperoxide bridge leading to increased oxidative stress in malaria parasites. The purpose of this study was to ascertain the antiparasitic effects of combining ferrocene and Ars via short or long chain ester or amide linkages (C1-C4). The compounds were evaluated for growth inhibition activity on the apicomplexan parasites, Plasmodium falciparum ( P. falciparum ) and Toxoplasma gondii ( T. gondii ). All the complexes demonstrated good activity against T. gondii with IC |
Databáze: | MEDLINE |
Externí odkaz: |